2 min listen
Pharma and Biotech Daily: Investment Highlights and Industry Insights
Pharma and Biotech Daily: Investment Highlights and Industry Insights
ratings:
Length:
1 minute
Released:
Mar 1, 2024
Format:
Podcast episode
Description
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Abingworth has invested in Trodelvy development in a deal with Gilead, where one of the investment firm's startups will work with Gilead to expand the cancer drug's label. Cure Ventures has backed a cell therapy startup called Kenai Therapeutics targeting Parkinson's, with $82 million raised and chaired by Jeff Jonas, a former CEO of Sage Therapeutics. Former Turning Point executives have started a new startup with Blossomhill, focusing on cancer and autoimmune diseases and raising over $170 million in funding. Lindus Health, co-founded by a Moderna co-founder Robert Langer, is aiming to address challenges in contract drug research. Ginkgo has acquired Proof Diagnostics, founded by Feng Zhang, to gain gene editing tools for making genetic medicines.In other news, there is an inside look at biotech financing tools, a theory on protein chirality, settlement agreements in price-fixing cases, and upcoming webinars on omnichannel HCP engagement and tech talent recruitment in the life sciences industry. Biopharma Dive provides insights and news on biotech and pharma trends, covering topics such as clinical trials, FDA approvals, gene therapy, drug pricing, and research partnerships.
Released:
Mar 1, 2024
Format:
Podcast episode
Titles in the series (47)
Biotech Breakthroughs: Advancements in MS Treatment, Cancer Detection, and Targeted Therapies by Pharma and BioTech Daily